Recombinant SARS-CoV-2 S-Trimer vaccine(Binhui Biotechnology)

重组新冠病毒S三聚体蛋白疫苗（滨会生物）

Report date: 2025/07/29 20:00:11

Base Information

Drug NameRecombinant SARS-CoV-2 S-Trimer vaccine(Binhui Biotechnology)
Drug Alias NameRecombinant SARS-CoV-2 S-Trimer Vaccine (CHO Cell)(Binhui Biotechnology)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesWuhan Binhui Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWuhan Binhui Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A